Anila Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-06-2024
- Paid Up Capital ₹ 5.10 M
as on 24-06-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 24-06-2024
About Anila Medical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹8.00 Cr.
The Key Managerial Personnel (KMP) at Anila Medical Private Limited India are Hans Jain as CFO and Sanjay Jain as Ceo. Rupesh Shah and Narasaiah Arigela serve as directors at the Company.
- CIN/LLPIN
U51909MP2020PTC051475
- Company No.
051475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2020
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anila Medical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hans Jain | CFO | 01-Dec-2021 | Current |
| Sanjay Jain | CEO | 01-Dec-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Shah  | Nominee Director | 04-Aug-2021 | Current |
| Narasaiah Arigela | Nominee Director | 04-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Anila Medical.
Anila Medical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anila Medical?
Unlock access to Anila Medical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Dhruvi Healthcare Private LimitedActive 2 years 9 months
Rupesh Shah and Narasaiah Arigela are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Sep 2021 | ₹8.00 Cr | Open |
How Many Employees Work at Anila Medical?
Anila Medical has a workforce of 76 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anila Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anila Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
